Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Immunomedics Inc (NASDAQ:IMMU)

4.62
Delayed Data
As of May 27
 +0.29 / +6.70%
Today’s Change
1.50
Today|||52-Week Range
5.05
+50.49%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Immunomedics Inc have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 5.00. The median estimate represents a +8.23% increase from the last price of 4.62.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in Immunomedics Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.11
Sales
$28.5M
Reporting Date
Aug 18

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 26.67%
 
 
 
 
 
Growthannually -8.82%
 
 
 
 
 
 

Sales

Growthquarterly 3,075.47%
 
 
 
 
 
Growthannually 501.44%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.